Pinsent Masons Advises NEXA Enterprise Asset Management on Acquisition By Transcat Inc

02 Sep 2021 | 10:48 am |

Multinational law firm Pinsent Masons has advised NEXA on its acquisition by Transcat Inc.

Cork-based NEXA Enterprise Asset Management (‘NEXA’) has been acquired by Nasdaq listed Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation

Founded in Ireland in 2015 by Dublin native, 37-year-old John Cummins, NEXA provides calibration optimisation and other technical solutions to improve asset- and reliability-management programs to pharmaceutical, biotechnology, and medical device companies worldwide. NEXA employs 25 in Ireland and another 40 in its Pennsylvania based US subsidiary.

The multi-disciplinary Pinsent Masons team was led by Dublin based Corporate partner Dennis Agnew and included, Gavin Hickey, Ciara Ruane, Nicola Barden, Matthew Mooney, Con Berkery and Clare McCourt. Pinsent Masons worked side by side with US firm Nelson Mullins.

Commenting on the deal Dennis said: “This is an important and exciting development for NEXA, I congratulate NEXA CEO John Cummins. John will continue in a leadership role in the new company and I have no doubt that the collaboration with Transcat Inc. will strengthen the offering to clients and push them forward as leaders in their field."

Latest press releases

Show me all press releases

Pinsent Masons announces new co-heads of Madrid, Inmaculada Castelló and Fernando Gutiérrez

Multinational law firm Pinsent Masons has appointed Inmaculada Castelló and Fernando Gutiérrez as co-heads of the Madrid office as of 1 September 2022.

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

Pinsent Masons advises climate-tech venture capital fund, Systemiq Capital, on the $70m closing of its second fund

Multinational law firm Pinsent Masons has advised climate-tech VC fund Systemiq Capital on the $70 million first close of its second fund, targeting $200 million to continue backing the best early-stage climate tech entrepreneurs.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises UMS Consulting on its acquisition by Expleo

Multinational law firm Pinsent Masons has advised the shareholders of UMS Consulting GmbH & Co. KG on the sale of their shares to Expleo Group S.A.S.

Pinsent Masons advises climate-tech venture capital fund, Systemiq Capital, on the $70m closing of its second fund

Multinational law firm Pinsent Masons has advised climate-tech VC fund Systemiq Capital on the $70 million first close of its second fund, targeting $200 million to continue backing the best early-stage climate tech entrepreneurs.

Pinsent Masons Advises Accord Healthcare in Exclusive Licence Agreement with Myovant Sciences to Commercialise ORGOVYX® for Advanced Hormone-Sensitive Prostate Cancer in Europe

Pinsent Masons represented Accord Healthcare Ltd in an exclusive license agreement with Myovant Sciences to commercialise relugolix, Myovant’s advanced hormone-sensitive prostate cancer treatment, under the trade name ORGOVYX® in the European Economic Area, United Kingdom, Switzerland and Turkey.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts